A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Yadi Zhou(Cleveland Clinic Lerner College of Medicine), Feixiong Cheng(Cleveland Clinic Lerner College of Medicine), Lara Jehi(Cleveland Clinic Lerner College of Medicine), Jiayu Shen(Jilin University), Serpil C. Erzurum(Mayo Clinic in Arizona), Asha Kallianpur(Cleveland Clinic Lerner College of Medicine), Charis Eng(Cleveland Clinic), Claudio Fiocchi(Cleveland Clinic Lerner College of Medicine), Samar Farha(Cleveland Clinic), Thaddeus S. Stappenbeck(Cleveland Clinic), Joe Zein(Mayo Clinic in Arizona), Jae U. Jung(Cleveland Clinic), Reena Mehra(Mayo Clinic in Arizona), Timothy Chan(Cleveland Clinic Lerner College of Medicine), Daniel A. Culver(Cleveland Clinic), Suzy Comhair(Cleveland Clinic), Yuan Hou(Cleveland Clinic Lerner College of Medicine), Michaela U. Gack(Cleveland Clinic Florida)
PLoS Biology
November 6, 2020
Cited by 186


Related Papers